Related references
Note: Only part of the references are listed.Niacin improves renal lipid metabolism and slows progression in chronic kidney disease
Kyu-hyang Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
PPARα and dyslipidemia
Caroline Duval et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States - Perface
AJ Collins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Acute tubular injury causes dysregulation of cellular cholesterol transport proteins
RA Zager et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression
ACM Johnson et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failure
KH Liang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells
DY Li et al.
CIRCULATION (2000)
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
TMA Bocan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
